- Wide-field Ca2+ imaging in head-fixed adult C57BL/6J mice tracked dorsal cortical activity across propofol anesthesia depth and emergence, with EEG-EMG and behavioral video used to define anesthesia stages.
- The design compared cortical activity and inter-regional functional connectivity between pre-anesthesia wake and post-emergence recovery, and across the propofol stages studied.
- Inter-regional correlation fell after emergence and stayed below pre-anesthesia baseline for at least 1.5 hours, e.g., MO-SS 0.82 ± 0.02 vs 0.67 ± 0.03 (P < 0.05), even as local Ca2+ activity recovered.
- The authors conclude that restoration of large-scale network coordination lags behind return of consciousness, suggesting a dissociation between local activity recovery and network integration.
Pharmacology
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Double-blinded randomized phase I/II trial of 58 participants with radicular pain from lumbosacral spinal stenosis.
- Transforaminal injection of sterile amniotic fluid filtrate was compared with dexamethasone, with safety and pain and function outcomes followed to 6 months.
- At 3 months, more dexamethasone patients had at least 50% pain reduction: back 45.8% vs 15.0% (P=.050) and leg 60.0% vs 25.0% (P=.034).
- Adverse event rates were comparable between groups with no serious intervention-related events, and the trial was stopped early after dexamethasone showed greater benefit.
- Preclinical study of 20 aged mice (18–20 months) with 24-hour EEG recordings, comparing propofol, an intralipid vehicle, and baseline controls.
- Propofol was infused to surgical-level anesthesia, titrated to EEG delta waves, with an equal volume of intralipid as the vehicle comparator.
- Propofol mice had more wakefulness (820 ± 93.3 vs 658 ± 71.1 min; P < .001) and less NREM sleep (539 ± 93.3 vs 699 ± 64.2 min; P < .001) than controls.
- Early after emergence, REM sleep fell (4.31 ± 2.81 vs 23.1 ± 8.26 min; P < .001), and the authors report delayed REM rebound despite satisfied NREM homeostasis.
- A quality improvement project with retrospective pre- and post-intervention data compared PACU narcotic use in pediatric dental patients.
- The intervention combined an intraoperative dexmedetomidine bolus with evidence-based education bundles for PACU nurses and CRNAs.
- Narcotic administration in the PACU decreased significantly after the intervention (p < 0.001), with no reported numeric effect size or confidence interval in the abstract.
- The authors conclude the bundle reduced postoperative narcotic use, with no significant change in length of stay.
- Single-center randomized trial of 98 adults undergoing elective unilateral total knee arthroplasty, with patients, surgeons, and outcome assessors blinded.
- Opioid-sparing anesthesia built on esketamine and dexmedetomidine was compared with conventional opioid-based anesthesia, and both groups had a femoral nerve block and multimodal analgesia.
- At 24 hours, QoR-15 was higher with opioid-sparing anesthesia (118.4 vs 113.3; adjusted difference 5.12, 95% CI 0.51-9.74; P=0.029), and this persisted at 48 hours.
- The authors concluded the strategy improved early QoR-15 scores, but the difference did not reach the minimal clinically important difference; lower PONV, lower CRP, and better 1-month Oxford Knee Score were also reported.
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- Retrospective cohort from the TriNetX US network of adults having major solid tumour surgery from 2014 to 2023, with 29,547 propensity-matched pairs drawn from 176,149 eligible patients.
- Perioperative ketamine on the day of surgery was compared with matched patients who did not receive it.
- Ketamine was not associated with lower 3-year mortality (16.7% vs 16.0%; HR 1.04; 95% CI 1.00-1.09; q=0.187), and 5-year mortality did not differ.
- An exploratory composite of cancer-progression surrogates was lower with ketamine (HR 0.82; 95% CI 0.74-0.92; q=0.013), but the authors conclude there was no mortality benefit.